Today’s top gainers include the company Zoetis Inc. (NYSE:ZTS) which is in the industry Drugs – Generic, gaining -2.21% today. In the last week its performance is 1.08%, and 11.88% for the past quarter. Currently, Zoetis Inc., ZTS has a target price of 54.5, so today’s gain of -2.21% is a significant step towards its target price. The GAP today is therefore -0.55%.
Zoetis Inc. (NYSE:ZTS), has a market cap of 26075.6, and is based in USA. Insider ownership is at 0.01%, and institutional ownership is 95.50%.
At the current price of 51.38, it has a dividend yield of 0.72%, and its target price is 54.5. This is with a profit margin of 13.20%, and total debt/equity of 3.29. Zoetis Inc. (NYSE:ZTS) has a P/E of 41.05, as well as a forward P/E of 22.74.
With a current EPS of 1.28, and a forecasted EPS growth for next year at 21.77%,Zoetis Inc. (NYSE:ZTS) has had a EPS growth for the past five years at 25.10%. For the next five years EPS growth is projected to be 12.58%.
Performance for the year is 14.22%. Since its IPO date on 2/1/2013, the total performance to date is 10.34%.
Volume today for Zoetis Inc. (NYSE:ZTS), is 2630692, while its average volume is 3076.23. Whilst the total gain today was -2.21%, it did have a day high of -2.39%.
Volatility for this week has been at 1.04%, and 1.24% for the month. The 52-week low for Zoetis Inc., ZTS has been 37.31%, while the 52-week-high has reached -2.39%.
Looking at its return of investments, which is 5.70%, and its return on assets is 8.60%. Zoetis Inc. (NYSE:ZTS) has an operating margin of 20.70%. With a sales growth of 2.80% quarter over quarter. Bearing in mind that Zoetis Inc., ZTS is in the sector Healthcare, its long-term debt/equity is 3.29, and has a current ratio of 3.2 and 1.7 for quick ratio.
So what is the value of Zoetis Inc.? Well its PEG is 3.26, and the P/S is 5.37, along with a P/B of 19.25. Meanwhile it has a p/cash of 39.63.